HIIT in Sedentary Obese Adults: Effects on Metabolic Risk, Body Composition, and FABP4
NCT ID: NCT06973980
Last Updated: 2025-05-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
28 participants
INTERVENTIONAL
2025-03-01
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of HIIT on Plasma Volume and Aerobic Capacity in Obese Adolescent Girls
NCT07046520
12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat
NCT03912272
Effectiveness of High-intensity Interval Training (HIIT) Versus Moderate-intensity Continuous Training (MICT) in Reducing Visceral Fat in Adults With Central Obesity
NCT04545320
Interval Training and Cardio-metabolic Health in Overweight/Obese Girls
NCT06538714
Evaluation of Lifestyle Modification on Cardiovascular Risk
NCT05417698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Studies have shown that FABP4 is associated with hypertension, insulin resistance, obesity, and stroke.
Inhibition of FABP4 synthesis has emerged as a promising strategy for the treatment of obesity-related conditions, particularly insulin resistance and diabetes, and it is emphasized that exercise models to suppress FABP4 should be further investigated.
The aim of this study is to investigate the effects of high-intensity interval training (HIIT) on cardiometabolic risk factors, body composition, and plasma FABP4 levels in sedentary obese adults.
Hypotheses:
H01: HIIT has no effect on cardiometabolic risk factors in sedentary obese adults.
H02: HIIT has no effect on body composition in sedentary obese adults. H03: HIIT has no effect on plasma FABP4 levels in sedentary obese adults.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Group
High-Intensity Interval Training (HIIT)
1-minute interval, 1-minute active recovery 5-minute warm-up, 3-minute cool-down at 60% of peak heart rate.
Weeks 1-2:
Intensity at 85% of peak heart rate during work, active recovery at 60% of peak heart rate, 4 sets of 1-minute work.
Weeks 2-7:
Intensity at 90% of peak heart rate during work, active recovery at 60% of peak heart rate, 6 sets of 1-minute work.
Weeks 8-12:
Intensity at 90% of peak heart rate during work, active recovery at 60% of peak heart rate, 8 sets of 1-minute work.
Exercise
The exercises will be applied only to the intervention group for 12 weeks and will be progressively intensified every 4 weeks.
Control Group
No intervention will be applied to the control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
The exercises will be applied only to the intervention group for 12 weeks and will be progressively intensified every 4 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI between 30 and 35 kg/m²,
* Waist circumference of 90-100 cm for women, 105-110 cm for men,
* Sedentary lifestyle (\<600 MET-min/week),
* Referred by a physician (with a statement confirming no contraindication to exercise)."
Exclusion Criteria
* Pregnancy,
* Cardiovascular Diseases: Individuals with serious cardiovascular issues, such as uncontrolled hypertension, heart failure, coronary artery disease, or a heart attack within the last 6 months, which could pose a risk during exercise.
* Respiratory Diseases: Individuals with chronic respiratory conditions, such as uncontrolled or severe asthma or COPD, who cannot tolerate exercise due to their condition.
* Neurological Disorders: Individuals with neurological issues that limit exercise capacity, such as Parkinson's disease, stroke, or multiple sclerosis.
* Musculoskeletal Issues: Individuals with chronic musculoskeletal problems, particularly knee or hip osteoarthritis, that may increase the risk of pain or injury during exercise.
* Metabolic or Endocrine Disorders: Individuals with uncontrolled metabolic issues, such as diabetes or thyroid disorders, that could cause blood sugar or hormonal fluctuations during exercise.
* Acute Infections or Illness: Individuals with acute infections, fever, or recently undergone surgical procedures.
* Any health condition that may prevent participation in exercise."
20 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eastern Mediterranean University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
YAŞAM DİREL, MSc
Role: PRINCIPAL_INVESTIGATOR
Eastern Meditterean university
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eastern Mediterranean University
Famagusta, , Cyprus
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
YDIREL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.